Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen

Transplantation

Volumn 62, Issue 6, 1996, Pages 831-836

  Schumacher, Ingo K ^a   Newberg, Michael H ^b   Jackson, John D ^a   Hammel, James M ^a   Rubocki, Ronald J ^a   Engelhard, Victor H ^b   Fox, Ira J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHIMERA; GENE EXPRESSION; GENE THERAPY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0029785313     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609270-00022     Document Type: Article

References (35)

1. Ellison MD, Breen TJ, Glascock F, McGaw LC, Daily OP. Organ donation in the United States: 1988 through 1991. In: Terasaki, Cecka, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 119.
2. Edwards EB, Breen TJ, Guo T. The UNOS-OPTN waiting list: 1988 through November 30, 1992. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 61.
3. Cooper DKC. Xenografting: how great is the clinical need? Xeno 1993; 1: 25.
4. Fox, IJ, Sindhi R, Shaw BW. Xenografts: do they have a role? Bailliere's Clin Gastroenterol 1994; 8: 441.
5. Auchincloss H. Xenogeneic transplantation. Transplantation 1988; 45: 1.
6. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 170.
7. Miller AD. Progress towards human gene therapy. Blood 1990; 76: 271.
8. Fox, IJ, Ethan A, Fisher, J, Baxter BT, Podda S, Richardson C. Use of gene therapy to induce human-mouse xenogeneic chimerism. Surgery 1993; 114: 174.
9. Le A-XT, Bernhard EJ, Holterman MJ, et al. Cytotoxic T cell responses in HLA-A2.1 transgenic mice: recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J Immunol 1989; 142: 1366.
10. Crumpacker DB, Alexander J, Cresswell P, Engelhard VH. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen processing mutant 174xCEM,T2. J Immunol 1992; 148: 3004.
11. Engelhard VH, Le AX, Holterman MJ. Species-specific structural differences in the a1 and a2 domains determine the frequency of murine cytotoxic T cell precursors stimulated by human and murine class I molecules. J Immunol 1988; 141: 1835.
12. Herman A, Parham P, Weissman SM, Engelhard VH. Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer. Proc Natl Acad Sci USA 1983; 80: 5056.
13. Yu J, Webster M, Fox IJ. Clonal deletion: a mechanism of tolerance in mixed bone marrow chimeras. J Surg Res 1990; 48: 517.
14. Hughes PF, Eaves CJ, Hogge DE, Humphries RK. High efficiency gene transfer to human hematopoietic cells maintained in long-term culture. Blood 1989; 74: 1915.
15. Ennis PD, Zemmour J, Salter RD, Parham P. Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc Natl Acad Sci USA 1990; 87: 2833.
16. Podda S, Ward M, Himelstein A, et al. Transfer and expression of the human multiple drug resistence gene into live mice. Proc Natl Acad Sci 1992; USA 89: 9676.
17. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
18. Epstein SL, Ozato K, Sachs DH. Blocking of allogeneic cell-mediated lympholysis by monoclonal antibodies to H-2 antigens. J Immunol 1980; 125: 129.
19. Krause DS, Ito T, Fackler MJ, et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 1994; 84: 691.
20. Ramsdell F, Fowlkes BJ. Maintanance of in vivo tolerance by persistence of antigen. Science 1992; 257: 1130.
21. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody: evidence of a clear role for short-term antigen presentation. Transplantation 1995; 59: 1367.
22. Nolta JA, Kohn DB. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1990; 1: 257.
23. Ogawa M. Differentiation and proliferation of stem cells Blood 1993; 81: 2844.
24. Bienzle D, Abrams-Ogg AC, Kruth SA, et al. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA 1994; 91: 350.
25. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995; 86: 101.
26. Spangrude GJ, Heimfeld S, Weissman IL Purification and characterization of mouse hematopoietic stem cells Science 1988; 241: 58.
27. Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 1991; 77: 1218.
28. Brown J, Greaves MF, Molgaard HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in hematopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 1991; 3: 175.
29. Fraser CC, Sykes M, Lee RS, Sachs DH, LeGuerin C. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway. J Immunol 1995; 154: 1587.
30. Qin S, Cobbold S, Benjamin R, Waldman H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 779.
31. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989; 169: 493.
32. Sharabi Y, Aksentijevich T, Sundt TM III, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a non-lethal preparative regimen. J Exp Med 1990; 172: 195.
33. Li H, El-Ezz AYA, Gambrell, BE, Ildstad ST. Mixed xenogeneic chimerism and tolerance III. A non-lethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts. Transplantation 1995; 60: 59.
34. Chester CH, Sykes M, Sachs DH. Multiple mixed chimeras: reconstitution of lethally irradiated mice with syngeneic plus allogeneic bone marrow from multiple strains. Res Immunol 1989; 140: 503.
35. Ally BA, Hawley TS, McKall-Faienza KJ, et al. 1995. Prevention of autoimmune disease by retroviral-mediated gene therapy. J Immunol 1995; 155: 5404.